These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5797826)

  • 1. Pulmoary tubercular lesions modified by chemotherapy.
    Goyl RK; Arora HL; Sharma ML
    J Indian Med Assoc; 1969 Feb; 52(3):101-3. PubMed ID: 5797826
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of corticotherapy on the residual pulmonary lesions after antitubercular chemotherapy].
    Araszkiewicz W
    Gruzlica; 1969 Mar; 37(3):223-34. PubMed ID: 5814946
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infrastructural study of experimental pulmonary lesions caused by Mycobacterium kansasii associated with dust in the guinea pig].
    Collet A; Devulder B; Normand-Reuet C
    Rev Tuberc Pneumol (Paris); 1967; 31(6):727-48. PubMed ID: 5622514
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 5. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermittent chemotherapy].
    Zierski M
    Gruzlica; 1968 Dec; 36(12):1241-6. PubMed ID: 5718178
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily and intermittent regimens: third IUAT chemotherapy investigation. A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. Clinical aspects.
    Bignall JR
    Bull Int Union Tuberc; 1970 Jun; 43():253-4. PubMed ID: 4193293
    [No Abstract]   [Full Text] [Related]  

  • 8. Short course chemotherapy of pulmonary tuberculosis and its possible impact on epidemiology of disease.
    Mehrotra ML; Gautam KD; Chaube CK
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):195-202. PubMed ID: 7166353
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of classical chemotherapy in in-patient and out-patient treatment of freshly detected pulmonary tuberculosis].
    Kuczborski S
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):339-41. PubMed ID: 5897864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Restorative processes in the chemotherapy of destructive pulmonary tuberculosis].
    Novoselova VP; Ertli AA
    Probl Tuberk; 1979 Apr; (4):59-63. PubMed ID: 441059
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of antimicrobial properties of actinomyces, isolated in patients with pulmonary tuberculosis treated with phthivazid and streptomycin].
    Nikiforchin RN
    Probl Tuberk; 1971; 49(7):66-71. PubMed ID: 5169485
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences with ethionamide in chronic drug-failure cases of pulmonary tuberculosis.
    Mitra A
    Minerva Medicoleg; 1965; 85(3):29-33. PubMed ID: 5879932
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of INH- and streptomycin-resistant patients].
    Böszörményi M; Schweiger O
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):329-31. PubMed ID: 5897861
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):342-3. PubMed ID: 5897865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of tuberculosis in children].
    Mayol PM; Alvarez Pagán M
    Bol Asoc Med P R; 1967 Jan; 59(1):20-5. PubMed ID: 5298814
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.